Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime

被引:5
|
作者
Jairam, Ravi Kumar [1 ]
Mallurwar, Sadanand R. [1 ]
Gabani, Bhavesh B. [1 ]
Zakkula, Ashok [1 ]
Kiran, Vinay [1 ]
Dittakavi, Sreekanth [1 ]
Sulochana, Suresh P. [1 ]
Mohd, Zainuddin [1 ]
Srinivas, Nuggehally R. [2 ]
Mullangi, Ramesh [1 ]
机构
[1] Drug Metab & Pharmacokinet, 2nd Stage, Bangalore 560022, Karnataka, India
[2] Jubilant Gener Ltd, Noida, Uttar Pradesh, India
关键词
Cefuroxime; ocular pharmacokinetics; rabbits; intravenous; intravitreal; intracameral; topical; tissues uptake; disposition; ANTIBIOTIC-RESISTANCE; SAFETY; ENDOPHTHALMITIS; TOXICITY; MODELS; FLORA;
D O I
10.1080/00498254.2019.1624872
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Cefuroxime is one of the widely used antibiotics. The objective of this study was to determine pharmacokinetics and disposition in various ocular tissues following topical (TOP), intracameral (IC) and intravitreal (IVT) administration of cefuroxime to rabbits. 2. Following TOP, IC and IVT dosing plasma and various ocular tissues (aqueous humor (AH), vitreous humor (VH), conjunctiva, trabecular mesh (TM), lens and retina-choroid (RC)) were collected and analyzed to understand the disposition of cefuroxime. Postintravenous administration plasma samples were collected to determine the systemic pharmacokinetics. 3. Post-TOP dosing cefuroxime concentrations were observed only in conjunctiva up to 48 h. IC administration showed cefuroxime concentrations in AH up to 8 h; in conjunctiva, TM and plasma, the concentration lasted up to 4 h and in RC and VH till 1 h. IVT administration of cefuroxime showed concentrations in all ocular tissues (up to 8 h) and lasted up to 48 h except in conjunctiva and RC. 4. There was evidence that the mechanism(s) of cefuroxime entry into the eye by via IVT, IC and TOP routes is clearly different. The present ocular tissue data may aid clinicians for considering appropriate choice in the treatment of post-operative ocular complications due to bacterial infections including endophthalmitis.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 45 条
  • [41] MINIMAL EFFECTS OF 2 ALDOSE REDUCTASE INHIBITORS, AL-1576 AND AL-4114, AFTER SUBACUTE TOPICAL-OCULAR DOSING ON XENOBIOTIC BIOTRANSFORMATION IN RABBITS
    SASTRY, SG
    SANDERS, RA
    VELTMAN, JC
    WATKINS, JB
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (10) : 1094 - 1098
  • [42] Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys-Evidence for half-life extension by albumin
    Fuchs, Holger
    Chen, Lin-Zhi
    Low, Sarah
    Yu, Hongbin
    EXPERIMENTAL EYE RESEARCH, 2021, 205
  • [43] Pharmacokinetics and disposition of monoterpene glycosides derived from Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic XueBiJing injection in human subjects and rats
    Cheng, Chen
    Lin, Jia-zhen
    Li, Li
    Yang, Jun-ling
    Jia, Wei-wei
    Huang, Yu-hong
    Du, Fei-fei
    Wang, Feng-qing
    Li, Mei-juan
    Li, Yan-fen
    Xu, Fang
    Zhang, Na-ting
    Olaleye, Olajide E.
    Sun, Yan
    Li, Jian
    Sun, Chang-hai
    Zhang, Gui-ping
    Li, Chuan
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (04) : 530 - 544
  • [44] Pharmacokinetics and disposition of monoterpene glycosides derived from Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic XueBiJing injection in human subjects and rats
    Chen Cheng
    Jia-zhen Lin
    Li Li
    Jun-ling Yang
    Wei-wei Jia
    Yu-hong Huang
    Fei-fei Du
    Feng-qing Wang
    Mei-juan Li
    Yan-fen Li
    Fang Xu
    Na-ting Zhang
    Olajide E. Olaleye
    Yan Sun
    Jian Li
    Chang-hai Sun
    Gui-ping Zhang
    Chuan Li
    Acta Pharmacologica Sinica, 2016, 37 : 530 - 544
  • [45] Relevance of NHP safety studies for ocular delivery of AAV-based gene therapy in humans: Example of GS010 (rAAV2/2-ND4) local tolerability, shedding and immunogenicity for the treatment of Leber Hereditary Optic Neuropathy (LHON), after intravitreal (IVT) injection in non-human primates (NHP) and in LHON patients
    Thomasson, Nitza
    Galy, Anne
    Fitoussi, Serge
    Meunier, Sandrine
    Uretsky, Scott
    Combal, Jean-Philippe
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)